Watson, Amneal fail to get order denying dismissal of Colcrys US antitrust case reconsidered
MLex Summary: Watson Laboratories and Amneal Pharmaceuticals have failed to convince a US judge to reconsider dismissing claims that they illegally conspired to delay market entry for a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article